Ex-ante regulations and ex-post liabilities for using a new technology will induce additional costs for adopters. The standard model is advanced by including irreversibility and uncertainty and taking into account transaction costs of negotiating possible cost reductions. The case analysed is the coexistence policy for GM crops in the European Union. Results show, the design of the rules and regulations can provide strong incentives for regional agglomeration of GM and non-GM farmers.
No takes yet. Share an insight, caveat, or question.
A 2010 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: